Zurich has revealed that less than 1% of its critical illness claims were declined for non-disclosure last year.
Overall it paid 91% of claims received in 2010 with 8% declined for not meeting the illness definition. In total the provider paid out £60.3m in benefits to 787 claimants, a slight decrease on the 2009 figures of £62.3m from 814 cases. Cancer remains the most common condition accounting for half of total critical illness claims paid, followed by heart attack (12%) stroke (7%) and multiple sclerosis (3%). The small non-disclosure rate is particularly significant as the industry has been working hard over the last few years, particularly at the underwriting stage, to reduce this prob...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes